We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

109 hedge funds and large institutions have $237M invested in Enzo Biochem, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

26% more capital invested

Capital invested by funds: $188M → $237M (+$48.7M)

6% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 35

0% more funds holding

Funds holding: 109 → 109 (0)

Holders
109
Holders Change
–
Holders Change %
0%
% of All Funds
2.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
37
Reduced
35
Closed
9
Calls
$357K
Puts
–
Net Calls
+$357K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$22.4M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.7M
3
CA
Corrado Advisors
New Jersey
+$2.12M
4
PI
Putnam Investments
Massachusetts
+$1.82M
5
MAG
Millrace Asset Group
Pennsylvania
+$1.06M

Top Sellers

Rank Fund Capital Flow
1
GC
Globeflex Capital
California
-$1.42M
2
EI
EAM Investors
California
-$661K
3
BCM
Bridgeway Capital Management
Texas
-$634K
4
Morgan Stanley
Morgan Stanley
New York
-$610K
5
PA
Perceptive Advisors
New York
-$582K
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$1.62M -$65.4K -9,284 -5%
Invesco
27
Invesco
Georgia
$1.54M +$976K +138,576 +309%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$1.51M +$185K +26,191 +17%
EI
29
EAM Investors
California
$1.39M -$661K -93,857 -36%
Two Sigma Investments
30
Two Sigma Investments
New York
$1.36M +$382K +54,282 +50%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.35M +$84.6K +12,004 +8%
MAG
32
Millrace Asset Group
Pennsylvania
$1.26M +$1.06M +150,000 New
TA
33
Teachers Advisors
New York
$1.18M +$202K +28,722 +26%
OSAM
34
O'Shaughnessy Asset Management
Connecticut
$1M -$73.8K -10,478 -8%
Goldman Sachs
35
Goldman Sachs
New York
$1M -$48.5K -6,885 -5%
EGA
36
Eagle Global Advisors
Texas
$939K – – –
NFA
37
Nationwide Fund Advisors
Ohio
$921K +$157K +22,331 +25%
Federated Hermes
38
Federated Hermes
Pennsylvania
$914K +$759K +107,800 +7,465%
Charles Schwab
39
Charles Schwab
California
$880K – – –
KCM
40
Kempner Capital Management
Texas
$799K +$179K +25,475 +36%
WCM
41
Wedge Capital Management
North Carolina
$702K – – –
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$654K -$25.4K -3,600 -4%
SO
43
STRS Ohio
Ohio
$647K -$139K -19,700 -20%
Morgan Stanley
44
Morgan Stanley
New York
$537K -$610K -86,588 -57%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$477K – – –
CCM
46
Corsair Capital Management
New York
$466K -$181K -25,755 -32%
NCCM
47
Nine Chapters Capital Management
New Jersey
$422K +$137K +19,500 +63%
UBS Group
48
UBS Group
Switzerland
$396K -$45.9K -6,522 -12%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$373K +$12.4K +1,762 +4%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$340K +$7 +1 +0%
1
2
3 4 5

ENZ Hedge Fund Activity: Q1 2017 in Review

109 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2017, worth a combined $237M — up 26% from $188M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ENZ positions and 9 closed out — a net gain of 5 holders — while 37 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $22.4M. The largest seller was Globeflex Capital, cutting an estimated $1.42M.

  • 109 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $237M of Enzo Biochem, Inc. stock for Q1 2017, up 26% quarter-over-quarter.
  • 14 funds opened new Enzo Biochem, Inc. positions in Q1 2017 and 9 closed out, a net change of +5 holders.
  • The largest Enzo Biochem, Inc. buyer in Q1 2017 was BlackRock, an estimated $22.4M added.
  • The largest Enzo Biochem, Inc. seller in Q1 2017 was Globeflex Capital, an estimated $1.42M sold.

Based on aggregated 13F filings for Q1 2017.